Opioid agonist therapy adherence trajectories among commercially and publicly insured people living with Hepatitis C in the United States

By afschroeder • July 15, 2025

Psaras C, Arah OA, Chew KW, Lee SJ, Javanbakht M, Nianogo RA, Seamans MJ. Opioid agonist therapy adherence trajectories among commercially and publicly insured people living with Hepatitis C in the United States. Epidemiology. 2025 Jul 4. doi: 10.1097/EDE.0000000000001895. Epub ahead of print. PMID: 40658042.

Tags: Analgesics, buprenorphine, chronic, Hepacivirus, Hepatitis C, Infectious Diseases, medication adherence, methadone, opioid, Opioid-Related Disorders, Publications

Illicit opioids, methamphetamine/amphetamine, and cocaine use are associated with loss of housing and delay with becoming rehoused across seven diverse cohorts with and without HIV in the United States and Canada

Delaney JA, Drumright LN, Newcomb ME, Milloy MJ, Smith MS, Mandler R, Swenson B, Fahey CA, DeBeck K, Metha S, Genberg BL, Mustanski B, Whitney[...]

Timeliness of routine childhood vaccination in the Democratic Republic of the Congo: data from national vaccine surveys in 2021/2022, 2023 and 2024

Mutwadi Malembe A, Nkamba Mukadi D, Hoff NA, Merritt S, Halbrook M, Mafuta Musalu E, Kasonga Ngindu JB, Babakazo P, Mandja Makasa BA, Kanyinda Kayembe[...]

Successful Treatment of an Atypical Mycobacterial Exit Site Infection in a Patient on Peritoneal Dialysis: A Case Report

Shye M, Sircar AD, Malchira R, Schulze C, Martin WJ. Successful Treatment of an Atypical Mycobacterial Exit Site Infection in a Patient on Peritoneal Dialysis:[...]